Science
At Experimentica we dedicate a significant amount of state-of-the-art methods for defining a broad array of ophthalmic indications.
Capabilities
We apply deep technology expertise to successfully advance innovative ophthalmic drugs and provide quality read-outs.
Collaborative R&D projects
Together with our partners from academia and industry we are participating in a number of extramurally funded research programs among others on diabetic retinopathy, development of artificial cornea and ocular surface diseases.
By on October 8, 2020
Experimentica receives 1.09 m€ in EU funding for the development of a human cornea transplantation model along with long-time partner Ferentis UAB....
By on August 5, 2020